EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors

Rishikesh Lotke iD, Moritz Petersen, Daniel Sauter iD

Viruses · 2024

DOI: 10.3390/v16030332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Rishikesh Lotke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, 72076 Tübingen, Germany. Hauptthemen laut MEDLINE: Protease Inhibitors, Viruses. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Medical Faculty Tübingen, German Center for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human genome is estimated to encode more than 500 proteases performing a wide range of important physiological functions. They digest proteins in our food, determine the activity of hormones, induce cell death and regulate blood clotting, for example. During viral infection, however, some proteases can switch sides and activate viral glycoproteins, allowing the entry of virions into new target cells and the spread of infection. To reduce unwanted effects, multiple protease inhibitors regulate the proteolytic processing of self and non-self proteins. This review summarizes our current knowledge of endogenous protease inhibitors, which are known to limit viral replication by interfering with the proteolytic activation of viral glycoproteins. We describe the underlying molecular mechanisms and highlight the diverse strategies by which protease inhibitors reduce virion infectivity. We also provide examples of how viruses evade the restriction imposed by protease inhibitors. Finally, we briefly outline how cellular protease inhibitors can be modified and exploited for therapeutic purposes. In summary, this review aims to summarize our current understanding of cellular protease inhibitors as components of our immune response to a variety of viral pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protease InhibitorsVirusesHumansGlycoproteinsProteolysisPeptide Hydrolases

Stichwörter der Autor:innen

TMPRSS2antiviral host factorsfurinproteaseprotease inhibitorserpinsviral glycoprotein

Substanzen

Protease InhibitorsGlycoproteinsPeptide Hydrolases

Autor:innen und Institutionen

  • Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, 72076 Tübingen, Germany.

ORCID-Profile: Rishikesh Lotke, Daniel Sauter

Förderung

  • Deutsche Forschungsgemeinschaft
  • Medical Faculty Tübingen
  • German Center for Infection Research
  • German Research Foundation (DFG)
  • German Center for Infection Research (DZIF) to M.P.
  • Medical Faculty Tübingen (Interdisziplinäres Promotionskolleg Medizin) to M.P.

Zitieren

APA

Lotke, R., Petersen, M., & Sauter, D. (2024). Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors. Viruses. https://doi.org/10.3390/v16030332

Vancouver

Lotke R, Petersen M, Sauter D. Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors. Viruses. 2024. doi:10.3390/v16030332

BibTeX
@article{Lotke2024,
  author = {Lotke, Rishikesh and Petersen, Moritz and Sauter, Daniel},
  title = {Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16030332}
}
Kostenlos starten →